Episode

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

Podcast: Few & Far Between: How Biotech Gets Built
Published: Mar 18, 2025
Duration seconds: 3122
Processing state: not_requested
Canonical source: https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova
Audio: https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/1995082/c1e-wm7m9u3jvgocxm7m9-5z1602ndc1kk-cj7jx2.mp3
JSON: /v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova
Markdown: /podcast/few-far-between-how-biotech-gets-built-4067896/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova.md

Actions

POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/epsiode-50-jonathan-rigby-chairman-and-ceo-sernova.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Now on the Few & Far Between podcast: Did you know that one in ten people with Type 1 Diabetes (TD1) die from hypoglycemia? Today's guest, who has TD1, explains how he turned his passion for helping others into innovative treatments for diabetes and other chronic diseases. Host Chris O'Brien welcomes Jonathan Rigby, Chairman and CEO at Sernova, to the podcast. Listen in as we spotlight Jonathan's 30-year industry journey, the development of implantable bio-hybrid organs, and how to plan for your first 30 days in a new biotech role. Tune in today!